SCHEMBL23985261

SCHEMBL23985261

COc1ccc(CN2C(=O)c3cc(-c4ccc5ncnn5c4)cc(N)c3C2c2cc(F)ccc2Cl)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.42
TNIK Q9UKE5 2/20 0.40
DYRK1A Q13627 1/20 0.37
MAPT P10636 3/20 0.35
GRIN1 Q05586 1/20 0.34
GRIN2B Q13224 1/20 0.34
KDM4E B2RXH2 4/20 0.33
ALOX15 P16050 3/20 0.33
ALDH1A1 P00352 3/20 0.33
HSD17B10 Q99714 2/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
HKDC1 Q2TB90 1/20 0.33
PIK3CD O00329 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
SCN5A Q14524 1/20 0.33
SLC6A2 P23975 3/20 0.33
SLC6A4 P31645 3/20 0.33
SLC6A3 Q01959 3/20 0.33
TGFBR1 P36897 1/20 0.33
TSHR P16473 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30305407 1.00 JAK2 (0.42) JAK2TNIKDYRK1AMAPTGRIN1
SCHEMBL30305418 0.91 TNIK (0.40) JAK2TNIKMAPTGRIN1GRIN2B
SCHEMBL30305429 0.91 TNIK (0.40) JAK2TNIKMAPTGRIN1GRIN2B
SCHEMBL23985262 0.91 TNIK (0.40) JAK2TNIKMAPTGRIN1GRIN2B
SCHEMBL30305529 0.87 JAK2 (0.39) JAK2TNIKDYRK1AMAPTALDH1A1
SCHEMBL23985115 0.87 JAK2 (0.39) JAK2TNIKDYRK1AMAPTALDH1A1
SCHEMBL23985263 0.84 TNIK (0.37) JAK2TNIKMAPTGRIN1GRIN2B
SCHEMBL23985259 0.84 MKNK2 (0.38) JAK2TNIKMAPTGRIN1GRIN2B
SCHEMBL23985120 0.83 TNIK (0.39) JAK2TNIKMAPTALDH1A1HSD17B10
SCHEMBL30305463 0.83 TNIK (0.39) JAK2TNIKMAPTALDH1A1HSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230353959-A1 PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. 2023-11-02 US disclosed
US-20230353959-A1 PI3K-ALPHA INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. 2023-11-02 US disclosed
WO-2021222556-A1 PI3K-α INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2021-11-04 WO disclosed